Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apolipoproteins A | 13 | 2016 | 25 | 2.460 |
Why?
|
| Internship and Residency | 3 | 2019 | 283 | 1.330 |
Why?
|
| Apolipoproteins B | 6 | 2016 | 44 | 1.140 |
Why?
|
| Physician-Patient Relations | 3 | 2019 | 169 | 1.130 |
Why?
|
| Death | 2 | 2018 | 41 | 1.080 |
Why?
|
| Triglycerides | 8 | 2016 | 214 | 0.910 |
Why?
|
| Interpersonal Relations | 2 | 2018 | 54 | 0.880 |
Why?
|
| Lipid Metabolism | 8 | 2013 | 100 | 0.840 |
Why?
|
| Lipoproteins, VLDL | 5 | 2016 | 27 | 0.830 |
Why?
|
| Lipoproteins | 6 | 2008 | 82 | 0.700 |
Why?
|
| Child, Hospitalized | 1 | 2019 | 8 | 0.690 |
Why?
|
| Physician-Nurse Relations | 1 | 2018 | 4 | 0.680 |
Why?
|
| Nurse-Patient Relations | 1 | 2018 | 3 | 0.680 |
Why?
|
| Students, Medical | 1 | 2019 | 121 | 0.600 |
Why?
|
| Medical History Taking | 1 | 2016 | 32 | 0.590 |
Why?
|
| Protein Structure, Tertiary | 8 | 2010 | 95 | 0.580 |
Why?
|
| Protein Structure, Secondary | 4 | 2010 | 45 | 0.510 |
Why?
|
| Trust | 1 | 2014 | 39 | 0.490 |
Why?
|
| Medicine in Literature | 1 | 2013 | 2 | 0.480 |
Why?
|
| Intestinal Absorption | 1 | 2013 | 12 | 0.470 |
Why?
|
| Mentors | 1 | 2013 | 29 | 0.470 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2013 | 32 | 0.470 |
Why?
|
| Fatty Acids | 1 | 2013 | 93 | 0.450 |
Why?
|
| Polymorphism, Genetic | 3 | 2010 | 196 | 0.450 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 481 | 0.450 |
Why?
|
| Funeral Rites | 1 | 2012 | 1 | 0.430 |
Why?
|
| Judaism | 1 | 2012 | 1 | 0.430 |
Why?
|
| Physicians | 1 | 2013 | 134 | 0.410 |
Why?
|
| Growth and Development | 1 | 2011 | 1 | 0.410 |
Why?
|
| Intestinal Mucosa | 2 | 2011 | 64 | 0.410 |
Why?
|
| Protein Isoforms | 2 | 2010 | 56 | 0.390 |
Why?
|
| Humans | 23 | 2019 | 29123 | 0.360 |
Why?
|
| Fatty Liver | 3 | 2016 | 66 | 0.330 |
Why?
|
| Spectrometry, Fluorescence | 5 | 2010 | 24 | 0.310 |
Why?
|
| Liver | 3 | 2016 | 464 | 0.300 |
Why?
|
| Diet | 2 | 2013 | 355 | 0.280 |
Why?
|
| Circular Dichroism | 4 | 2010 | 30 | 0.250 |
Why?
|
| Thermodynamics | 4 | 2010 | 45 | 0.250 |
Why?
|
| Animals | 12 | 2016 | 7300 | 0.250 |
Why?
|
| Transfection | 6 | 2012 | 192 | 0.230 |
Why?
|
| Schools, Medical | 1 | 2002 | 42 | 0.220 |
Why?
|
| Employment | 1 | 2002 | 49 | 0.220 |
Why?
|
| Cholesterol Esters | 1 | 2002 | 37 | 0.210 |
Why?
|
| Mutation | 3 | 2005 | 466 | 0.210 |
Why?
|
| Social Support | 1 | 2002 | 163 | 0.200 |
Why?
|
| Carrier Proteins | 4 | 2016 | 131 | 0.200 |
Why?
|
| Spinal Puncture | 1 | 2019 | 20 | 0.170 |
Why?
|
| Injections, Spinal | 1 | 2019 | 124 | 0.170 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 39 | 0.170 |
Why?
|
| Ethics, Research | 1 | 2018 | 25 | 0.160 |
Why?
|
| Liposomes | 3 | 2007 | 26 | 0.160 |
Why?
|
| Water | 3 | 2008 | 50 | 0.160 |
Why?
|
| Informed Consent | 1 | 2018 | 51 | 0.160 |
Why?
|
| Dietary Fats | 2 | 2011 | 108 | 0.150 |
Why?
|
| Apolipoproteins | 3 | 2010 | 196 | 0.150 |
Why?
|
| Abdominal Pain | 1 | 2016 | 40 | 0.150 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 18 | 0.150 |
Why?
|
| Diarrhea | 1 | 2016 | 56 | 0.140 |
Why?
|
| Lipids | 4 | 2005 | 210 | 0.140 |
Why?
|
| Female | 5 | 2019 | 18173 | 0.140 |
Why?
|
| Spectrophotometry | 2 | 2008 | 21 | 0.140 |
Why?
|
| Protein Binding | 4 | 2007 | 199 | 0.140 |
Why?
|
| Recombinant Proteins | 4 | 2007 | 248 | 0.140 |
Why?
|
| Kinetics | 6 | 2007 | 205 | 0.140 |
Why?
|
| Infant | 1 | 2019 | 969 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2016 | 118 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2016 | 370 | 0.130 |
Why?
|
| Tetracycline | 2 | 2012 | 11 | 0.120 |
Why?
|
| Male | 5 | 2016 | 17815 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 32 | 0.120 |
Why?
|
| Doxycycline | 2 | 2012 | 25 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 2 | 2004 | 24 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 546 | 0.120 |
Why?
|
| Protein Transport | 2 | 2012 | 74 | 0.120 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 6 | 0.120 |
Why?
|
| Particle Size | 2 | 2011 | 42 | 0.120 |
Why?
|
| COS Cells | 2 | 2003 | 28 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 711 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2008 | 280 | 0.110 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 350 | 0.110 |
Why?
|
| Dimyristoylphosphatidylcholine | 3 | 2007 | 5 | 0.110 |
Why?
|
| Stroke | 1 | 2018 | 548 | 0.110 |
Why?
|
| Rats | 3 | 2012 | 1604 | 0.110 |
Why?
|
| Culture Media | 1 | 2012 | 39 | 0.100 |
Why?
|
| Peptide YY | 1 | 2011 | 1 | 0.100 |
Why?
|
| Lymphatic Vessels | 1 | 2011 | 5 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 11 | 0.100 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2011 | 11 | 0.100 |
Why?
|
| Triolein | 2 | 2008 | 2 | 0.100 |
Why?
|
| Biological Transport | 1 | 2011 | 62 | 0.100 |
Why?
|
| Oleic Acid | 3 | 2010 | 7 | 0.100 |
Why?
|
| Mice | 3 | 2013 | 2371 | 0.100 |
Why?
|
| Catheterization | 1 | 2011 | 58 | 0.100 |
Why?
|
| Chickens | 2 | 2008 | 40 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 212 | 0.100 |
Why?
|
| Eating | 1 | 2011 | 73 | 0.100 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2010 | 1 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2010 | 34 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2010 | 178 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 681 | 0.090 |
Why?
|
| Body Weight | 1 | 2011 | 290 | 0.090 |
Why?
|
| Chylomicrons | 2 | 2005 | 6 | 0.090 |
Why?
|
| Adsorption | 1 | 2008 | 5 | 0.080 |
Why?
|
| Molecular Conformation | 1 | 2008 | 8 | 0.080 |
Why?
|
| Aged | 3 | 2018 | 9492 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2011 | 327 | 0.080 |
Why?
|
| Gene Expression | 2 | 2013 | 332 | 0.080 |
Why?
|
| Middle Aged | 3 | 2018 | 10834 | 0.080 |
Why?
|
| Mutagenesis | 2 | 2005 | 32 | 0.080 |
Why?
|
| Golgi Apparatus | 2 | 2004 | 8 | 0.070 |
Why?
|
| Lipoproteins, LDL | 1 | 2006 | 77 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2005 | 85 | 0.070 |
Why?
|
| Models, Biological | 1 | 2008 | 373 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2005 | 64 | 0.070 |
Why?
|
| Intestines | 1 | 2005 | 54 | 0.070 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2005 | 38 | 0.070 |
Why?
|
| Adult | 2 | 2018 | 8426 | 0.060 |
Why?
|
| Apolipoprotein A-I | 1 | 2005 | 68 | 0.060 |
Why?
|
| Protein Sorting Signals | 1 | 2004 | 6 | 0.060 |
Why?
|
| Cholesterol | 2 | 2005 | 229 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2016 | 425 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2003 | 11 | 0.060 |
Why?
|
| Tritium | 1 | 2003 | 17 | 0.060 |
Why?
|
| Phosphatidylcholines | 1 | 2003 | 21 | 0.060 |
Why?
|
| Air | 1 | 2003 | 6 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 82 | 0.060 |
Why?
|
| Protein Folding | 1 | 2003 | 28 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 66 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 81 | 0.060 |
Why?
|
| Software | 1 | 2003 | 109 | 0.050 |
Why?
|
| Postprandial Period | 1 | 2002 | 10 | 0.050 |
Why?
|
| Teaching | 1 | 2002 | 55 | 0.050 |
Why?
|
| Pressure | 1 | 2002 | 54 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 97 | 0.050 |
Why?
|
| Time Factors | 2 | 2005 | 2001 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 1017 | 0.050 |
Why?
|
| Genotype | 1 | 2002 | 735 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2003 | 422 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 1379 | 0.050 |
Why?
|
| Disulfides | 2 | 2010 | 34 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2016 | 40 | 0.040 |
Why?
|
| Patient Selection | 1 | 2018 | 257 | 0.040 |
Why?
|
| Research Design | 1 | 2018 | 286 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2016 | 183 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 35 | 0.030 |
Why?
|
| Acute Disease | 1 | 2016 | 239 | 0.030 |
Why?
|
| Atherosclerosis | 2 | 2013 | 698 | 0.030 |
Why?
|
| Cell Line | 2 | 2005 | 450 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 6 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2010 | 5 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 17 | 0.020 |
Why?
|
| CHO Cells | 1 | 2010 | 25 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 58 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2010 | 98 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 980 | 0.020 |
Why?
|
| Cysteine | 1 | 2010 | 131 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2008 | 97 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 799 | 0.020 |
Why?
|
| Calcinosis | 1 | 2008 | 143 | 0.020 |
Why?
|
| Radiography | 1 | 2008 | 353 | 0.020 |
Why?
|
| Adiposity | 1 | 2008 | 191 | 0.020 |
Why?
|
| Copper Sulfate | 1 | 2006 | 1 | 0.020 |
Why?
|
| Amidines | 1 | 2006 | 2 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 34 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 60 | 0.020 |
Why?
|
| Guanidine | 1 | 2006 | 3 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2006 | 7 | 0.020 |
Why?
|
| Octoxynol | 1 | 2006 | 7 | 0.020 |
Why?
|
| Buffers | 1 | 2006 | 9 | 0.020 |
Why?
|
| Histidine | 1 | 2006 | 5 | 0.020 |
Why?
|
| Spodoptera | 1 | 2006 | 4 | 0.020 |
Why?
|
| Detergents | 1 | 2006 | 17 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2006 | 40 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2005 | 33 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 25 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 27 | 0.020 |
Why?
|
| Light | 1 | 2006 | 25 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 33 | 0.020 |
Why?
|
| Kidney | 1 | 2010 | 486 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 42 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2005 | 5 | 0.020 |
Why?
|
| Oils | 1 | 2005 | 3 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 74 | 0.020 |
Why?
|
| Binding Sites | 1 | 2006 | 125 | 0.020 |
Why?
|
| Amino Acids | 1 | 2006 | 41 | 0.020 |
Why?
|
| Antioxidants | 1 | 2006 | 114 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 250 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 99 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2006 | 82 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2005 | 111 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2005 | 12 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2005 | 71 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 248 | 0.020 |
Why?
|
| Swine | 1 | 2005 | 201 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 172 | 0.020 |
Why?
|
| DNA Primers | 1 | 2005 | 87 | 0.020 |
Why?
|
| RNA | 1 | 2005 | 88 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2005 | 281 | 0.020 |
Why?
|
| Base Sequence | 1 | 2005 | 240 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 1362 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 1688 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 641 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 514 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 3537 | 0.010 |
Why?
|